Glenmark Pharma says USFDA has issued CRL for Ryaltris
Posted by
www.biotecnika.org
The CRL cites deficiencies in the Drug Master File pertaining to one
of the active pharmaceutical ingredients and in manufacturing
facilities, the company said in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-says-usfda-has-issued-crl-for-ryaltris/articleshow/69903560.cms
Subscribe to:
Post Comments (Atom)
Post a Comment